We are live on ! Find out more
NVAX icon

Novavax

153 hedge funds and large institutions have $889M invested in Novavax in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 19

43% more capital invested

Capital invested by funds: $623M → $889M (+$266M)

17% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 46

7% more funds holding

Funds holding: 143153 (+10)

74% less call options, than puts

Call options by funds: $2.17M | Put options by funds: $8.32M

Holders
153
Holders Change
+10
Holders Change %
+6.99%
% of All Funds
4.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
54
Reduced
46
Closed
19
Calls
$2.17M
Puts
$8.32M
Net Calls
-$6.15M
Net Calls Change
+$342K
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
26
McKinley Capital Management
Alaska
$5.92M -$31.7K -303 -0.6%
WHI
27
William Harris Investors
Illinois
$5.9M -$590K -5,648 -10%
Massachusetts Financial Services
28
Massachusetts Financial Services
Massachusetts
$5.62M +$4.95M +47,367 New
Millennium Management
29
Millennium Management
New York
$5.6M +$4.18M +39,965 +550%
SIP
30
Stoneridge Investment Partners
Pennsylvania
$5.39M +$824K +7,881 +21%
CCA
31
Catalyst Capital Advisors
New York
$5.02M +$52.3K +500 +1%
TCIM
32
TIAA CREF Investment Management
New York
$4.82M -$217K -2,081 -5%
Prudential Financial
33
Prudential Financial
New Jersey
$4.8M +$4.12M +39,380 +3,554%
NFA
34
Nationwide Fund Advisors
Ohio
$4.6M -$60.3K -577 -1%
EI
35
EAM Investors
California
$4.14M +$1.28M +12,241 +54%
Charles Schwab
36
Charles Schwab
California
$4.13M +$145K +1,392 +4%
GC
37
Guggenheim Capital
Illinois
$3.97M +$106K +1,012 +3%
HM
38
HealthCor Management
New York
$3.85M +$312K +2,989 +10%
BIM
39
BlackRock Investment Management
Delaware
$3.84M -$16.5K -158 -0.5%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$3.81M +$1.24M +11,847 +58%
RSCM
41
Rock Springs Capital Management
Maryland
$3.77M +$314K +3,000 +10%
PAM
42
Panagora Asset Management
Massachusetts
$3.7M +$1.29M +12,372 +66%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$3.57M +$517K +4,950 +20%
HCM
44
Harvey Capital Management
Florida
$3.53M +$521K +4,985 +20%
AIC
45
AWM Investment Company
New York
$3.38M +$2.98M +28,500 New
ERSOT
46
Employees Retirement System of Texas
Texas
$3.12M +$78.4K +750 +3%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$3.08M
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$2.71M +$596K +5,700 +33%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$2.63M +$22.4K +214 +1%
RFC
50
Russell Frank Company
Washington
$2.15M +$234K +2,239 +14%

NVAX Hedge Fund Activity: Q4 2014 in Review

153 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2014, worth a combined $889M — up 43% from $623M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NVAX positions and 19 closed out — a net gain of 13 holders — while 54 added to existing stakes and 46 trimmed.

The largest buyer was Invesco, adding an estimated $5.14M. The largest seller was Camber Capital Management, cutting an estimated $14.4M.

  • 153 institutional investors held Novavax (NVAX) as of Q4 2014, up from 143 in Q3 2014.
  • Funds reported $889M of Novavax stock for Q4 2014, up 43% quarter-over-quarter.
  • 32 funds opened new Novavax positions in Q4 2014 and 19 closed out, a net change of +13 holders.
  • The largest Novavax buyer in Q4 2014 was Invesco, an estimated $5.14M added.
  • The largest Novavax seller in Q4 2014 was Camber Capital Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q4 2014.